Molecular recognition of metabotropic glutamate receptor type 1 (mGluR1): Synergistic understanding with free energy perturbation and linear response modeling
- Seung-Gu Kang
- Payel Das
- et al.
- 2014
- Journal of Physical Chemistry B
Ajay Royyuru serves as Chief Science Officer for Healthcare & Life Sciences research at IBM. This team, part of Accelerated Discovery mission in IBM Research, is actively pursuing high quality science, developing novel technologies and achieving translational insights across this industry, including areas of cancer, cardiovascular & metabolic, neurological & mental health, immunological & infectious diseases.
Working with institutions around the world, he pursues science and technology approaches to accelerating discovery in healthcare and life sciences. His work has featured in The New York Times, The Washington Post, BBC, Forbes, Scientific American, Nature Medicine, and Nature news articles.
After his undergraduate and masters education in human biology and biophysics from All India Institute of Medical Sciences, New Delhi, Ajay obtained his Ph. D. in molecular biology from Tata Institute of Fundamental Research, Mumbai. He had postdoctoral training at Memorial Sloan-Kettering Cancer Center, New York and a brief stint at scientific software development before joining IBM Research.